Posts by Sandra Ansanay-Alex
HUG Innovation Day: A Pioneer Of New Therapies For Deafness Awarded
On the occasion of their 17th Innovation Day, held on 19 October, the Geneva University Hospitals (HUG), in partnership with the Faculty of Medicine of the University of Geneva (UNIGE), awarded the 2023 Innovation Prize to the project “The Phoenix platform – a catalyst for the development of new therapies for deafness” and two trophies…
Read MoreLagosta partners with Merck for the distribution of Chitosan
LAGOSTA S.A. announces that it has entered into a collaboration with the global science and technology company Merck for the distribution of LAGOSTA’s unique chitosan. Chitosan compound can be used by pharma, biotech and the biomedical industry for R&D use only, in drug delivery applications, 3D bioprinting and medical devices. Under the agreement,…
Read MoreMEDICA – COMPAMED
MEDICA and COMPAMED are taking place at the Düsseldorf Exhibition Centre in Germany from 16 to 19 November 2026 Visitors to this international trade fair will be able to discover all the facets of the global market for medical technology and medical products, and find answers to all their questions. Once again this year, the…
Read MoreEmovo Care receives a CHF 100’000 FIT loan
The FIT (Fondation pour l’Innovation Technologique) in Canton of Vaud supports Emovo Care with a FIT Tech Seed loans of CHF 100’000 Emovo Care isL spin-off. The start-up is at the forefront of medical technology with its innovative hand exoskeleton tailored for patients suffering from neurological or orthopaedic injuries. This groundbreaking device will…
Read MoreLimula wins the $250,000 BioTools Innovator Grand Prize
BioTools Innovator, a Los Angeles-based accelerator focused on life science tools companies, awarded Limula the grand prize of the BioTools Innovator 2023 Final competition. The swiss medtech company receives a $250,000 non-dilutive prize and the title of 2023 BioTools Innovator. Limula, an EPFL spin-off, offers an automated tool for scalable cell therapy manufacturing.…
Read MoreCNS Therapy secures a CHF 1.1 Million investment
The Jura-based start-up, CNS Therapy, has raised a seed round funding totalling CHF 1 Million from private investors and CHF 139,200 in Jura Cantonal funding. CNS Therapy is developing a drug-free pain relief management solution that combines the use of a patented medical device with interactive therapy. While many traditional treatments for chronic…
Read MoreSmartCardia received FDA clearance for its ECG monitoring patch and cloud platform
The EPFL-spin-off created the SmartCardia’s 7L patch, an easy-to-wear, cable-free, waterproof device that can be used for continuous monitoring for up to 14 days. SmartCardia’s 7L patch and cloud platform is a single solution that covers the entire spectrum of cardiac monitoring including screening, post-operative follow-up, and remote patient monitoring. It has been…
Read More4 new Medtech Start-Ups join the DayOne Tech Accelerator in Canton of Jura
The DayOne Tech accelerator for medtech project is a pillar of the Jura’s medical technology economy. Four new start-ups joined the programme and the six companies already involved in Courroux. They begin a 12-month acceleration programme with expert support. The aim is to propel them into the ranks of successful companies. Xana…
Read MoreInnovations at the CHUV in the treatment of lymphoedema
Swelling of one or more limbs as a result of lymphoedema – a common but little-understood condition – affects one in five women undergoing breast cancer surgery following the operation. The CHUV is offering two promising new methods for treating this condition. The lymphatic network comprises vessels, lymph nodes and organs that circulate…
Read MoreCHF 3 Million for Terapet and two South Korea partners
Terapet SA together with their South Korean partners Yonsei Cancer Center (Heavy Ion Therapy Center) and Oncosoft Inc. are awarded CHF 3 Million in non-dilutive funds through a bilateral innovation project funded by Innosuisse and the Korea Institute for Advancement of Technology (KIAT). Terapet SA, a Geneva-based CERN spin-off developing an innovative platform…
Read More